| 引用本文：吴庆艳,刘丽莎,龚敏希,等.省域层面中医优势病种疗效价值付费改革方案比较研究[J].中国卫生政策研究,2025,18(8):63-70 |
|
| 省域层面中医优势病种疗效价值付费改革方案比较研究 |
| 投稿时间：2025-07-10 修订日期：2025-08-09 PDF全文浏览 HTML全文浏览 |
| 吴庆艳1,2，刘丽莎1，龚敏希3，翟理祥2 |
| 1.广东药科大学医药商学院 广东广州 510006;2.广东省卫生经济与健康促进研究中心 广东广州 510006;3.广东药科大学财务与国有资产管理部 广东广州 510006 |
| 摘要:目的 通过8省中医优势病种疗效价值付费方案的对比研究，发现已有方案的不足，提出完善的政策建议。方法 对各地方案中的核心内容，病种选择、疗效评价指标、付费环节的应用和保障机制等方面，进行对比分析。结果 已有方案碎片化问题明显，各项具体内容设定差别较大，反映对方案核心内容理解存在明显差异，对中医疗效价值认识不统一，付费标准与疗效评价结果未挂钩，尤其对中医技术劳务价值缺乏认可等问题。结论 可借由中医突出优势选择病种，借鉴西医价值医疗的评价框架，构建中医疗效价值评价体系，并基于健康结果的“同效”开展“同价”支付，分阶段设置绩效指标并设定付费标准，实现疾病全过程的管理，发挥中医疗效价值，促进中医传承创新发展。 |
| 关键词:疗效价值 中医优势病种 付费 |
| 基金项目:2025年度广东省哲学社会科学规划一般项目（GD25CGG11）；2024 年度广东省哲学社会科学规划一般项目（GD24CGL29）；广东省普通高校创新团队项目（2022WCXTD011） |
|
| A comparative study on the payment reform for therapeutic value of dominant diseases of Traditional Chinese Medicine at provincial level |
| WU Qing-yan1,2, LIU Li-sha1, GONG Min-xi3, ZHAI Li-xiang2 |
| 1.School of Pharmaceutical Business， Guangdong Pharmaceutical University， Guangzhou Guangdong 510006， China;2.Guangdong Health Economy and Health Promotion Research Center， Guangzhou Guangdong 510006， China;3.Department of Finance and State-owned Assets Management， Guangdong Pharmaceutical University， Guangzhou Guangdong 510006， China |
| Abstract:Objective Through the comparative analysis of the payment program for the therapeutic value of Traditional Chinese Medicine dominant diseases in 8 provinces， we found the shortcomings of the existing program and put forward the perfect policy suggestions.Methods Comparative analysis of the core content of the programs in various places， the selection of disease types， efficacy evaluation indexes， the application of the payment link and the protection mechanism.Results The fragmentation of existing programs is an obvious problem，the specific content settings of each item are quite different， reflecting differences in the understanding of the core content of the program， the existence of inconsistent understanding of Chinese medicine's therapeutic value， the failure to link the payment standard to the results of the therapeutic value evaluation， and the lack of recognition of the value of Chinese medicine's technical labor， among other problems.Conclusions We can select disease types based on the prominent advantages of Traditional Chinese medicine， learn from the evaluation framework of western medicine value-based medical care， construct the evaluation system of Chinese medicine therapeutic value， and carry out "equal price" payment based on the "same effect" of health results， set performance indicators and payment standards in stages， realize the whole process management of disease， and enhance the Traditional Chinese Medicine's therapeutic value， and promote the development of Traditional Chinese Medicine inheritance and innovation. |
| Key words:Therapeutic value Dominant diseases of Traditional Chinese Medicine Payment |
| 摘要点击次数: 47 全文下载次数: 9 |
|
|
